And neither is a shortcut
The FDA itself will make the final decision, and the advisory vote is not equivalent to FDA approval
For a deeper overview of this peptide, read our BPC-157 research guide which explains its structure and research background
While supplementation with exogenous GSH has shown therapeutic potential on its own, recent findings indicate advantages to combined treatment with other immunomodulatory or anti-infective agents (Vairetti et al., 2021)
[ 3 ] Variations in species studied, routes of administration, dosing regimens, and experimental methodologies likely contributed to these conflicting results
However, one should not forget about the side effects of the drug, such as peripheral edema, facial flushing, pain, dizziness, palpitations, weakness, and others 98